
Journal of Medicinal Chemistry p. 486 - 497 (1994)
Update date:2022-08-05
Topics:
Raddatz, Peter
Minck, Klaus-Otto
Rippmann, Friedrich
Schmitges, Claus-Jochen
A series of novel renin inhibitors containing 2-(((3-phenylpropyl)phosphoryl)oxy)alkanoic acid moieties as P2-P3 surrogates are presented.The P2-P3 mimetics were obtained from (ω-phenylalkyl)phosphinic acids 1a-c and 2-hydroxyalkanoic acid benzyl esters 2a-f by N,N'-dicyclohexylcarbodiimide-mediated coupling and subsequent oxidation with sodium metaperjodate.Ester cleavage of these derivatives and coupling with P1-P'1 transition-state mimetics I-VII provided highly selective compounds with inhibitory potencies in the lower nanomolar range.Small renin inhibitors, such as analogues 8c and 8h with molecular weights of 539 and 537, respectively, could be prepared.These compounds exhibited IC50 values of about 20 nM against human plasma renin.Compound 7i was examined in vivo for its hypotensive effect.In salt-depleted cynomolgus monkeys, 7i inhibited plasma renin activity almost completely and lowered blood pressure after oral adiministration of a dose of 30 mg/kg.
View MoreLaizhou City Laiyu Chemical CO.,Ltd
Contact:+86-535-2719337/2719339
Address:Chenggang road zhuyou laizhou City Shangdong China
Contact:21-7631221 15884421033
Address:326 Science and technology,Shanghai,China
Shanghai Sunway Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-5161 3915
Address:Shanghai YangPu
website:http://www.chinacharm.cn/
Contact:86 551 5316260
Address:No. 211,XiangZhang Road,Hefei City,Anhui Province,China
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Doi:10.1021/jo00077a007
(1993)Doi:10.1021/tx960190k
(1997)Doi:10.1016/S0040-4039(00)73819-6
(1993)Doi:10.1016/j.jcat.2014.09.015
(2014)Doi:10.1021/jm00008a014
(1995)Doi:10.1016/0223-5234(93)90141-Z
(1993)